
Jeffrey D. Dunn, PharmD, MBA
Articles by Jeffrey D. Dunn, PharmD, MBA



Stakeholders, including national and regional managed care decision makers and providers, met to discuss the clinical background, health economics, and management strategies for pulmonary arterial hypertension (PAH) at a roundtable meeting on December 10, 2016, in Dallas, Texas.




This article is the first in a 2-part series that summarizes the proceedings from a roundtable meeting that was conducted to discuss real-world considerations in nonvalvular atrial fibrillation and venous thromboembolism.


Data about escalating prices for cancer drugs laid the groundwork for the panel that followed, where Michael E. Chernew, PhD, Harvard health economist and co-editor-in-chief of The American Journal of Managed Care, outlined how changing the paradigm will require a different kind of shopping.

Dr Cliff Goodman leads a discussion featuring panelists including The American Journal of Managed Care's co-editor-in-chief, Dr Michael Chernew. Topics of the discussion include the impact of value-based pricing in the market, and how different pricing models such as bundled payments or accountable care organizations impact risk factors.








Latest Updated Articles
- Evolving Knowledge of the Unmet Needs in Dry Eye Disease
Published: March 16th 2021 | Updated:
- Discussion 7: Value-Based Pricing: The Role of Outcomes Data in Pricing Models
Published: December 28th 2013 | Updated:
- Participating Faculty: Research to Real World Application: Experts Weigh In on the Underuse of Anticoagulants
Published: December 26th 2014 | Updated:
- Research to Real-World Application: Experts Weigh In on the Underuse of Anticoagulants
Published: December 26th 2014 | Updated:
- The Burden of Hyperkalemia in Patients With Cardiovascular and Renal Disease
Published: November 30th 2015 | Updated:
- Managed Care Considerations
Published: June 15th 2008 | Updated: